Finch Therapeutics Group (NASDAQ:FNCH – Get Rating) is one of 254 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Finch Therapeutics Group to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. […]